Thank you for attending our debate “How to strike a balance between transparency and confidentiality in the conduct of clinical trials?” (21 April)

PubAffairs Bruxelles was delighted to host on the 21st of April the debate “How to strike a balance between transparency and confidentiality in the conduct of clinical trials?” with our distinguished speakers Mr Thomas Heynisch, deputy Head of Unit, DG Growth, European Commission, Mr Fergal O’Regan, Head Of Unit, European Ombudsman and Mr Andrew Powrie-Smith, Communications Director at EPFIA.

We would like to thank our distinguished guests, our moderator, Professor Katelijne De Nys, Head of the Clinical Trial Center of the University Hospitals of Leuven and our sponsor, Hogan Lovells, for allowing this debate to take place on the 21st of April.

PubAffairs Bruxelles is also pleased to announce that the next event will take place on the 5th of May 2015.

We hope that all the contributors, attendees, as well as our present and future members will join us in the next debate.

#Eurozone: #ECB officials question whether #Euro has strengthened too much, by @OlafStorbeck and Ian Smith | Financial Times

Image for twitter card

ECB officials question whether euro has strengthened too much

Policymakers at central bank fret that a surging currency increases the risk of inflation undershooting

www.ft.com

[Featured] #Trade: #EU splits weaken its hand in crunch trade talks with #Trump, by @_Zimmerfrau and @_AriHawkins | Politico

Image for twitter card

EU splits weaken its hand in crunch trade talks with Trump

European capitals are pulling in different directions ahead of a decisive round of trade talks in Washington. 

www.politico.eu

#EUDefence: The Italian job - How #Rome plans to work around #NATO spending hike, by @giuseppe_fonte, @AmanteAngelo and Gavin Jones | Reuters 

Image for twitter card

The Italian job: how Rome plans to work around NATO spending hike

Italy, along with other NATO countries, has agreed to sharply increase defence spending over the next decade, but ...

www.reuters.com

Load More